Life Extension Final Clerance Sale

Liver Degenerative Disease

References

AMA. The American Medical Association Encyclopedia of Medicine 1989. New York: Random House.

Anon. Holistic Health Encyclopedia 2002. Oakford, PA: Telstar Innovations.

Attri, S., Rana, S.V., Vaiphie, K., Katyal, R., Sodhi, C.P., Kanwar, S., Singh, K. Protective effect of N-acetylcysteine in isoniazid induced hepatic injury in growing rats. Indian J. Exp. Biol. 2001 May; 39(5): 436-40.

Bergasa, N.V. Itching in Liver Disease 2002 Sep; New York: Columbia University.

Berson, A., De Beco, V., Letteron, P., Robin, M.A., Moreau, C., El Kahwaji, J., Verthier, N., Feldmann, G., Fromenty, B., Pessayre, D. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998 Apr; 114(4): 764-74.

Biewenga, G.P., Haenen, G.R., Bast, A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 1997 Sep; 29(3): 315-31.

Bosisio, E., Benelli, C., Pirola, O. Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol. Res. 1992 Feb-Mar; 25(2): 147-54.

Braillon, A., Capron, J.P., Herve, M.A., Degott, C., Quenum, C. Liver in obesity. Gut 1985 Feb; 26(2): 133-9

Brewer, G.J., Fink, J.K., Hedera, P. Diagnosis and treatment of Wilson's disease. Semin. Neurol. 1999; 19(3): 261-70.

Britton, R.S., Bacon, B.R. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 1994 Aug; 41(4): 34-8.

Chalasani, N., Gitlin, N. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Am. J. Gastroenterol. 1996 Jun; 91(6): 1266-8.

Chern, C.L., Huang, R.F., Chen, Y.H., Cheng, J.T., Liu, T.Z. Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed. Pharmacother. 2001 Oct; 55(8): 434-42

Day, C.P., Yeaman, S.J. The biochemistry of alcohol-induced fatty liver. Biochem. Biophys. Acta 1994 Nov 17; 1215(1-2): 33-48.

Deulofeu, R., Pares, A., Rubio, M., Gasso, M., Roman, J., Gimenez, A., Varela-Moreiras, G., Caballeria, J., Ballesta, A.M., Mato, J.M., Rodes, J. S-Adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats. Clin. Sci. 2000 Oct; 99(4): 315-20.

Feher, J., Vereckei, A., Lengyel, G. Role of free-radical reactions in liver diseases. Acta Physiol. Hung. 1992; 80(1-4): 351-61.

Fernandez, E., Pallini, R., Lauretti, L., La Marca, F., Sccgna, A., Rossi, G.F. Motonuclear changes after cranial nerve injury and regeneration. Arch. Ital. Biol. 1997 Sep; 135(4): 343-51.

Garg, M.C., Bansal, D.D. Protective antioxidant effect of vitamins C and E in streptozotocin induced diabetic rats. Indian J. Exp. Biol. 2000 Feb; 38(2): 101-4.

Genova, M.L., Bonacorsi, E., D'Aurelio, M., Formiggini, G., Nardo, B., Cuccomarino, S., Turi, P., Pich, M.M., Lenaz, G., Bovina, C. Protective effect of exogenous coenzyme Q in rats subjected to partial hepatic ischemia and reperfusion. Biofactors 1999; 9(2-4): 345-9.

Glanze, W.D., Ed. Mosby Medical Encyclopedia, Revised Edition 1996. St. Louis, MO: C.V. Mosby.

Gumina, G., Song, G.Y., Chu, C.K. Advances in antiviral agents for hepatitis B virus. Antivir. Chem. Chemother. 2001; 12(Suppl. 1): 93-117.

Hazai, E., Monostory, K., Bakos, A., Zacher, G., Vereczkey, L. About paracetamol again. Orv. Hetil. 2001 Feb 18; 142(7): 345-9 (in Hungarian).

Kato, M., Miwa, Y., Tajika, M., Hiraoka, T., Muto, Y., Moriwaki, H. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern. Med. 1998 May; 37(5): 429-34.

Khanna, S., Atalay, M., Laaksonen, D.E. et al. Alpha-lipoic acid supplementation: tissue glutathione homeostasis at rest and after exercise. J. Appl. Physiol. 1999 Apr; 86(4): 1191-6.

Lammert, F., Busch, N., Matern, S. Clinical aspects and therapy of viral hepatitis. Chirug 2000 Apr; 71(4): 381-8 (in German).

Lester GE, Jifon JL, Crosby KM. Superoxide dismutase activity in mesocarp tissue from divergent Cucumis melo L. genotypes. Plant Foods Hum Nutr. 2009 Sep;64(3):205-11.

Lieber, C.S. Prevention and treatment of liver fibrosis based on pathogenesis. Alcohol Clin. Exp. Res. 1999 May; 23(5): 944-9.

Lykkesfeld, J. et al. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes-reversal with R alpha lipoic acid supplementation. FASEB J. 1998; 12: 1183-9.

Ma, X., Zhao, J., Lieber, C.S. Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. J. Hepatol. 1996 May; 24(5): 604-13.

Malik, A.H., Lee, W.M. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann. Intern. Med. 2000 May 2; 132(9): 723-31.

Mayerat, C., Mantegani, A., Spertini, F., Frei, P.C. Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B. Eur. J. Clin. Microbiol. Infect. Dis. 1999 Dec; 18(12): 871-8.

Mirossay, L., Mojzis, J., Sallingova, Z. et al. Gastroprotective effect of malotilate in indomethacin- and ethanol-induced gastric mucosal damage. Physiol. Res. 1996; 45(5): 405-11.

Mydlik, M., Derzsiova, K., Racz, O., Sipulova, A., Boldizsar, J., Lovasova, E., Hribikova, M. Vitamin E as an antioxidant agent in CAPD patients. Int. J. Artif. Organs 2002 May; 25(5): 373-8.

Navender KP, Baraona E, Lieber CS. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr. 1997;127(9):1800-6.

NIDA. Hepatitis C. NIDA Community Drug Alert Bulletin 2002 Feb 21. Bethesda, MD: National Institute on Drug Abuse/National Institutes of Health/Department of Health and Human Services.

NIDDK. Cirrhosis of the Liver 2000 Jan. NIH Publ. No. 00-1134. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health.

Nidus. What are the primary treatments for cirrhosis? Well-Connected Report: Cirrhosis 1999 Mar. New York: Nidus Information Services (www.well-connected.com).

Ou, J.H.J. Viral hepatitis and its prevention. Infection Control Today Magazine 2002. Phoenix, AZ: Virgo Publishing.

Paradies, G., Petrosillo, G., Gadaleta, M.N., Ruggiero, F.M. The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett. 1999 Jul 9; 454(3): 207-9.

Pniachik, J., Baraona, E., Zhaoi, J., Lieber, C.S. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation. J. Lab. Clin. Med. 1999 Apr; 133(4): 342-8.

Rao, K.V., Qureshi, I.A. Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyper-ammonemia: prevention by acetyl-L-carnitine. Neuropharmacology 1999 Mar; 38(3): 383-94.

Ryhanen, L., Stenback, F., Ala-Kokko, L., Savolainen, E.R. The effect of malotilate on type III and type IV collagen, laminin and fibronectin metabolism in dimethylnitrosamine-induced liver fibrosis in the rat. J. Hepatol. 1996 Feb; 24(2): 238-45.

Sakaguchi, S., Iizuka, Y., Furusawa, S., Tanaka, Y., Takayanagi, M., Takayanagi, Y. Roles of selenium in endotoxin-induced lipid peroxidation in the rats liver and in nitric oxide production in J774A.1 cells. Toxicol. Lett. 200 Dec 20; 118(1-2): 69-77.

Shimazu, Y. An experimental and clinical study of energy-protein metabolism and host defense-repair mechanism in postoperative period-a significance of administration of branched chain amino acid. Nippon Geka Gakkai Zasshi 1990 Oct; 91(10): 1534-47 (in Japanese).

Sonnenbichler, J., Goldberg, M., Hane, L., Madubunyi, I., Vogl, S., Zetl, I. Stimulatory effect of silibinin on the DNA synthesis in partially hepatectomized rat livers: non-response in hepatoma and other malign cell lines. Biochem. Pharmacol. 1986a Feb 1; 35(3): 538-41.

Sonnenbichler, J., Zetl, I. Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog. Clin. Biol. Res. 1986b; 213: 319-31.

Strickland, D.K. Hepatitis C. eMed. J. 2002 Jan 16 (http://www.emedicine.com/ped/topic979.htm).

Takase, S., Matsuda, Y., Yasuhara, M., Takada, A. Effects of malotilate treatment on alcoholic liver disease. Alcohol 1989 May-Jun; 6(3): 219-22.

Teranishi, M., Karbowski, M., Kurono, C., Nishizawa, Y., Usukura, J., Soji, T., Wakabayashi, T. Effects of coenzyme Q10 on changes in the membrane potential and rate of generation of reactive oxygen species in hydrazine- and chloramphenicol-treated rat liver mitochondria. Arch. Biochem. Biophys. 1999 Jun 1; 366(1): 157-67.

Valenzuela, A., Aspillaga, M., Vial, S., Guerra, R. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med. 1989 Oct; 55(5): 420-2.

Vineis, P., Esteve, J., Terracini, B. Bladder cancer and smoking in males: types of cigarettes, age at start, effect of stopping and interaction with occupation. Int. J. Cancer 1984 Aug 15; 34(2): 165-70.

Vouldoukis I, Lacan D, Kamate C, et al. Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity. J Ethnopharmacol. 2004 Sep;94(1):67-75.

Wallace, L.A., Pellizzari, E.D., Hartwell, T.D., Davis, V., Michael, L.C., Whitmore, R.W. The influence of personal activities on exposure to volatile organic compounds. Environ. Res. 1989 Oct; 50(1): 37-55.

Wolf, D.C. Cirrhosis. eMed. J. 2001 Sep 6; 2(9) (http://www.emedicine.com/med/topic3183.htm).

Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M., Diehl, A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. U.S.A. 1997 Mar 18; 94(6): 2557-62.